A novel method to measure functional status of ErbB2 in breast cancer

被引：0
|
作者：
Kong, Anthony
Leboucher, Pierre
Leek, Russell
Winter, Stuart
Harris, Adrian
Parker, Peter
Larijani, Banafshe
机构：
[1] London Res Inst, Canc Res UK, London, England
[2] Coll France, Lab Physiol Percept & Act, Paris, France
[3] Univ Oxford, Inst Mol Med, Oxford, England
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1952
引用
收藏
页数：2
相关论文
共 50 条
  • [1] NASBA: a novel approach to assess hormonal receptors and ERBB2 status in breast cancer
    Lamy, PJ
    Verjat, T
    Paye, M
    Servanton, AC
    Grenier, J
    Leissner, P
    Mougin, B
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2006, 44 (01) : 3 - 12
  • [2] Molecular and functional characteristics of erbB2 in normal and cancer breast cells
    Tommasi, S
    Fedele, V
    Lacalamita, R
    Crapolicchio, A
    Perlino, E
    Bellizzi, A
    Paradiso, A
    CANCER LETTERS, 2004, 209 (02) : 215 - 222
  • [3] Comparative multi-methodological measurement of ERBB2 status in breast cancer
    Ginestier, C
    Charafe-Jauffret, E
    Penault-Llorca, F
    Geneix, JN
    Adélaïde, J
    Chaffanet, M
    Mozziconacci, MJ
    Hassoun, J
    Viens, P
    Birnbaum, D
    Jacquemier, J
    JOURNAL OF PATHOLOGY, 2004, 202 (03): : 286 - 298
  • [4] Role of erbB2 in breast cancer chemosensitivity
    Yu, DH
    Hung, MC
    BIOESSAYS, 2000, 22 (07) : 673 - 680
  • [5] ErbB2 diagnostics in breast cancer - an update
    Rueschoff, J.
    Nagelmeier, I.
    Hofmann, M.
    Henkel, Th.
    Stoss, O.
    PATHOLOGE, 2009, 30 (02): : 147 - 155
  • [6] ERBB2 amplicon passenger genes: A novel class of breast cancer antigens
    Plautz, Gregory E.
    Modi, Arun
    Wang, Li-Xin
    CANCER RESEARCH, 2014, 74 (19)
  • [7] Evaluation of ERBB2 gene status and chromosome 17 anomalies in male breast cancer
    Fonseca, Ricardo R.
    Tomas, Ana R.
    Andre, Saudade
    Soares, Jorge
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2006, 30 (10) : 1292 - 1298
  • [8] Prognosis in hormon receptor negative breast cancer patients according to ERBB2 status
    Dogan, L.
    Atalay, C.
    Yilmaz, K. B.
    Ozaslan, C.
    NEOPLASMA, 2008, 55 (06) : 544 - 548
  • [9] Flotillins as regulators of ErbB2 levels in breast cancer
    Pust, S.
    Klokk, T. I.
    Musa, N.
    Jenstad, M.
    Risberg, B.
    Erikstein, B.
    Tcatchoff, L.
    Liestol, K.
    Danielsen, H. E.
    van Deurs, B.
    Sandvig, K.
    ONCOGENE, 2013, 32 (29) : 3443 - 3451
  • [10] Evaluation of agents targeting ErbB2 in breast cancer
    Kuruppu, A.
    Zhang, L.
    Thomas, N.
    Bradshaw, T.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S209 - S209
12345